Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
World Neurosurg ; 142: 352-363, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32659357

RESUMEN

BACKGROUND: Acute colonic pseudo-obstruction (ACPO) or Ogilvie's syndrome occurs in 0.22%-7% of patients undergoing surgery, with a mortality of up to 46%. ACPO increased median hospital days versus control in spinal surgery (14 vs. 6 days; P < 0.001). If defined as postoperative ileus, the incidence was 7%-13.4%. Postoperative ileus is associated with 2.9 additional hospital days and an $80,000 increase in cost per patient. We present a case of ACPO in an adult patient undergoing spinal fusion for correction of scoliosis and review the available literature to outline clinical characteristics and surgical outcomes. CASE DESCRIPTION: The patient was a 31-year-old woman with untreated advanced scoliosis with no history of neurologic issues. T2-L3 spinal instrumentation and fusion was completed. Plain abdominal radiography showed of dilated cecum 11 cm and the department of general surgery was consulted. Neostigmine administration was planned after conservative treatment failure after transfer to the intensive care unit. The patient was discharged home with no recurrence >60 days. Thirty cases were found in our literature review using PubMed and Embase databases and summarized. CONCLUSIONS: Of 30 cases reviewed, only 3 cases of ACPO were specific to patients undergoing spinal fusion for scoliosis. According to the literature, 20% of patients had resolution with conservative treatment, 40% with neostigmine, and 30% with surgical intervention. Other noninvasive treatments may have similar efficacy in preventing complications leading to surgical invention. Sixty clinical trials and 9 systematic reviews were summarized with an updated management algorithm.


Asunto(s)
Seudoobstrucción Colónica/diagnóstico por imagen , Seudoobstrucción Colónica/etiología , Complicaciones Posoperatorias/diagnóstico por imagen , Complicaciones Posoperatorias/etiología , Fusión Vertebral/efectos adversos , Enfermedad Aguda , Adulto , Femenino , Humanos , Vértebras Lumbares/diagnóstico por imagen , Vértebras Lumbares/cirugía , Escoliosis/diagnóstico por imagen , Escoliosis/cirugía , Fusión Vertebral/tendencias , Vértebras Torácicas/diagnóstico por imagen , Vértebras Torácicas/cirugía
2.
Am Surg ; 83(9): 1012-1017, 2017 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-28958283

RESUMEN

There is no established national standard for rib fracture management. A clinical practice guideline (CPG) for rib fractures, including monitoring of pulmonary function, early initiation of aggressive loco-regional analgesia, and early identification of deteriorating respiratory function, was implemented in 2013. The objective of the study was to evaluate the effect of the CPG on hospital length of stay. Hospital length of stay (LOS) was compared for adult patients admitted to the hospital with rib fracture(s) two years before and two years after CPG implementation. A separate analysis was done for the patients admitted to the intensive care unit (ICU). Over the 48-month study period, 571 patients met inclusion criteria for the study. Pre-CPG and CPG study groups were well matched with few differences. Multivariable regression did not demonstrate a difference in LOS (B = -0.838; P = 0.095) in the total study cohort. In the ICU cohort (n = 274), patients in the CPG group were older (57 vs 52 years; P = 0.023) and had more rib fractures (4 vs 3; P = 0.003). Multivariable regression identified a significant decrease in LOS for those patients admitted in the CPG period (B = -2.29; P = 0.019). Despite being significantly older with more rib fractures in the ICU cohort, patients admitted after implementation of the CPG had a significantly reduced LOS on multivariable analysis, reducing LOS by over two days. This structured intervention can limit narcotic usage, improve pulmonary function, and decrease LOS in the most injured patients with chest trauma.


Asunto(s)
Cuidados Críticos , Mejoramiento de la Calidad , Fracturas de las Costillas/terapia , Adulto , Anciano , Algoritmos , Estudios de Cohortes , Femenino , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Pruebas en el Punto de Atención , Guías de Práctica Clínica como Asunto , Pruebas de Función Respiratoria , Fracturas de las Costillas/complicaciones , Fracturas de las Costillas/fisiopatología , Resultado del Tratamiento
4.
Curr Surg ; 61(2): 224-6, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15051269

RESUMEN

OBJECTIVE: To report the case of a patient with gemfibrozil-controlled hypertriglyceridemia (HTG) that developed acute pancreatitis several days after starting a high-fat ketogenic diet. METHODS: The patient was evaluated and treated by the authors. RESULTS: The patient denied viral prodrome or previous symptoms, ethanol consumption, or a known history of cholelithiasis. He was compliant with his gemfibrozil regimen. Clinical examination revealed a tachycardic, febrile, moderately distressed man with exquisite tenderness across the left flank and left abdomen. Laboratory studies revealed increased serum amylase (114 U/L), lipase (530 U/L) and triglyceride (>1000 mg/dL) concentrations. There was a borderline leukocytosis (12800 WBC/mm(3)). Computed tomography of the abdomen demonstrated enlargement and marked inflammatory change to the pancreas. Abdominal ultrasonography revealed no evidence of cholelithiasis or pancreatobiliary obstruction. These findings were diagnostic of HTG-induced acute pancreatitis. CONCLUSION: Ketogenic diets may cause a substantial increase in serum triglycerides and, as a result, may precipitate HTG-induced pancreatitis in those with abnormal lipid metabolism. Patients with a history of HTG should be advised of the potentially deleterious correlation between ketogenic diets and pancreatic function.


Asunto(s)
Grasas de la Dieta/efectos adversos , Gemfibrozilo/uso terapéutico , Hipertrigliceridemia , Hipolipemiantes/uso terapéutico , Pancreatitis/etiología , Dolor Abdominal/etiología , Enfermedad Aguda , Adulto , Amilasas/sangre , Carbohidratos de la Dieta/administración & dosificación , Fiebre/etiología , Humanos , Hipertrigliceridemia/complicaciones , Hipertrigliceridemia/tratamiento farmacológico , Hipertrigliceridemia/metabolismo , Cetonas/metabolismo , Lipasa/sangre , Masculino , Obesidad/complicaciones , Obesidad/dietoterapia , Obesidad/metabolismo , Pancreatitis/diagnóstico , Pancreatitis/metabolismo , Factores Desencadenantes , Taquicardia/etiología , Tomografía Computarizada por Rayos X , Triglicéridos/sangre
5.
Ann Vasc Surg ; 17(6): 656-62, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14569432

RESUMEN

This study evaluated the effect of fenoldopam, a selective dopamine (DA1) agonist, on renal blood flow and renal tubular function following renal ischemia induced by suprarenal aortic cross-clamping. Twenty anesthetized research pigs received either fenoldopam (10 micro g/kg/min; n = 10) or saline ( n = 10) beginning 20 min before suprarenal aortic cross-clamping and continuing for 20 min after clamp release, for a total infusion time of 160 min (120-min cross-clamp). Recordings of renal blood flow, mean arterial pressure, and heart rate were taken at baseline, during cross-clamping, and immediately postclamp. Ischemic renal injury was evaluated by serum creatinine and by histologic grading of acute tubular necrosis. Treatment with fenoldopam increased renal blood flow in comparison to that in the control group ( p = 0.03). The mean creatinine increase from baseline at 6 hr and 18 hr after cross-clamp removal for the fenoldopam-treated group was significantly less than that in the control group ( p < 0.001). On histologic evaluation, the mean score for the degree of tubular necrosis was significantly higher in the control group ( p = 0.02), indicating less derangement of tubular morphology in the fenoldopam group. This study demonstrated that the intraoperative use of a continuous infusion of fenoldopam during suprarenal aortic cross-clamping results in increased renal blood flow, less postoperative rise in creatinine, and better preservation of tubular histology in the pig model.


Asunto(s)
Lesión Renal Aguda/prevención & control , Agonistas de Dopamina/farmacología , Fenoldopam/farmacología , Túbulos Renales/efectos de los fármacos , Circulación Renal/efectos de los fármacos , Lesión Renal Aguda/etiología , Animales , Aorta Abdominal , Constricción , Creatinina/sangre , Cuidados Intraoperatorios , Necrosis Tubular Aguda/patología , Porcinos , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...